missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human Polypeptide GalNAc Transferase 4/GALNT4 Antibody, R&D Systems™

Sheep Polyclonal Antibody
Brand: R&D Systems AF7528-SP
This item is not returnable.
View return policy
Description
Polypeptide GalNac Transferase 4/GALNT4 Polyclonal specifically detects Polypeptide GalNac Transferase 4/GALNT4 in Human samples. It is validated for Western Blot.
Specifications
| Polypeptide GalNac Transferase 4/GALNT4 | |
| Polyclonal | |
| Western Blot 0.5 ug/mL | |
| Q8N4A0 | |
| GALNT4 | |
| Mouse myeloma cell line NS0-derived recombinant human Polypeptide GalNac Transferase 4/GALNT4 Ala36-Lys578 Accession # Q8N4A0 | |
| 25 μg | |
| Primary | |
| Detects human Polypeptide GalNac Transferase 4/GALNT4 in direct ELISAs and Western blots. In direct ELISAs, less than 1% cross-reactivity with recombinant human (rh) GALNT1 and rhGALNT3 is observed. | |
| Human | |
| IgG |
| Western Blot | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| EC 2.4.1.41, FLJ93314, GALNACT4, GALNAC-T4, Polypeptide GalNAc transferase 4, polypeptide N-acetylgalactosaminyltransferase 4, pp-GaNTase 4, Protein-UDP acetylgalactosaminyltransferase 4, UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 4, UDP-N-acetyl-alpha-D-galactosamine:polypeptideN-acetylgalactosaminyltransferase 4 (GalNAc-T4) | |
| Sheep | |
| Affinity Purified | |
| RUO | |
| 8693 | |
| Reconstitute at 0.2 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction